To determine if the expression of downstream genes of noncanonical Wnt signaling pathway could be altered by 6-BT administration, we used westernblot analysis of p-CaMKII, p-PKC, and p-Rac1 after HL-60 cells were treated with 0, 5,10 and 20 uM 6-BT for 3 days.
During 7-day treatment, the effect of the antiplatelet drugs was investigated using LTA and BT 3 hours after administration on days 1, 4 and 7.
The participants will be evaluated on three occasions: 1) one week prior to the administration of BT-A; 2) one week after the administration of BT-A; and 3) four months after the administration of BT-A (end of intervention).
Three evaluations will be carried out: Evaluation 1 One week prior to the administration of BT-A Evaluation 2 One week following the administration of BT-A Evaluation 3 Four months following the administration of BT-A (end of intervention protocol) Spasticity will be assessed using the Modified Ashworth Scale and Modified Tardieu Scale.
Following the administration of BT-A, physical therapy plays a fundamental role in potentiating the functionality of the child.
The protocol will last four months beginning with the administration of BT-A and will not undergo any alterations in this period.
All participants will be submitted to the administration of BT-A in the lower limbs, performed by a single specialist in physical rehabilitation.
Recent experimental studies have found that the use of neuromuscular electrical stimulation (NMES) following the administration of BT-A was beneficial in the treatment of spasticity, improving muscle function and gait parameters [ 1, 29] in patients with CP.
This paper offers a detailed description of a randomized, controlled, blinded, clinical trial aimed at demonstrating the effect of NMES on the dorsiflexors of the ankle following the administration of BT-A in the triceps surae in ambulatory children with diplegic spastic cerebral palsy.
All potential prognostic factors, including gender, age (≤45 years; >45 years), T-stage (T1, T2a, T2b), N-stage (0 3) and brachytherapy techniques (the administration of 3D-HDR-BT or 2D-HDR-BT) and EBRT techniques (2D-CRT, 3D-CRT & IMRT) were included in the Cox proportional hazards model by backward elimination of the insignificant explanatory variables.
